Search
Now showing items 1-2 of 2
An Uninformative Truth: The Logic of Amarin’s Off-Label Promotion
(Public Library of Science, 2016)
Spencer Phillips Hey and Aaron Kesselheim propose that informativeness—asserting scientific facts—rather than truthfulness ought to be the standard for regulating commercial speech about pharmaceuticals.
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
(Public Library of Science, 2016)
Ameet Sarpatwari and Aaron Kesselheim explore whether stripping branded drugs of trademark protection would improve the efficiency and fairness of health care.